ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
14.51
-0.28 (-1.89%)
Aug 15, 2025, 9:30 AM - Market open

ImageneBio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Mar '25 Dec '24 Dec '23
Net Income
-20.33-36.57-21.15
Depreciation & Amortization
0.891.533.1
Loss (Gain) From Sale of Assets
1.271.270
Loss (Gain) From Sale of Investments
---0.14
Other Operating Activities
0.1213.97-0.94
Change in Accounts Payable
2.04-0.523.89
Change in Unearned Revenue
-0.140.51-0.14
Change in Other Net Operating Assets
-3.29-1.5-2.85
Operating Cash Flow
-19.38-21.32-18.23
Capital Expenditures
---0.31
Sale of Property, Plant & Equipment
0.970.970
Investment in Securities
-10.15-10.15
Investing Cash Flow
0.9711.12-10.45
Short-Term Debt Issued
-7.5-
Total Debt Issued
7.57.5-
Net Debt Issued (Repaid)
7.57.5-
Issuance of Common Stock
0.05-0.15
Other Financing Activities
-0.61-0.59-
Financing Cash Flow
6.936.910.15
Foreign Exchange Rate Adjustments
-0.010.09-0.15
Net Cash Flow
-11.48-3.2-28.69
Free Cash Flow
-19.38-21.32-18.54
Free Cash Flow Margin
-450.79%-609.11%-232.83%
Free Cash Flow Per Share
-0.04-0.05-0.06
Cash Income Tax Paid
0.220.220.12
Levered Free Cash Flow
--21.2-
Unlevered Free Cash Flow
--21.2-
Change in Working Capital
-1.39-1.520.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q